Clinical trials offer patients access to promising new treatments which have not yet been approved. They offer an opportunity to help make new treatments available to all patients by helping to advance science. Patients in clinical trials receive high-quality care and are carefully followed.
HOW TO FIND INFORMATION ON THE LATEST TRIALS
The IMF’s Myeloma Matrix is a great website resource that lists myeloma drugs currently under development and tracks them from discovery to approval. The Myeloma Matrix is continuously updated by the InfoLine Team so visitors to the page get up-to-the-minute status information about myeloma drugs in all stages of development—from Pre-Clinical to FDA Approved.
Learn more about clinical trials from the Coalition of Cancer Cooperative Groups. The coalition is a group of nine organizations that are called cooperative groups. The cooperative groups bring together hundreds of institutions to conduct the large, Phase III trials that compare therapies and are often critical in getting new therapies approved